Atypical Hemolytic Uremic Syndrome (aHUS) Recruiting Phase 4 Trials for Eculizumab (DB01257)

Back to Atypical Hemolytic Uremic Syndrome (aHUS)

Also known as: Atypical Hemolytic Uraemic Syndrome / Atypical Hemolytic-Uremic Syndrome / Atypical Hemolytic Uremic Syndrome / Hemolytic-Uremic Syndrome, Atypical / Hemolytic Uremic Syndrome, Atypical / Atypical hemolytic uremic syndrome (disorder) / Atypical haemolytic uraemic syndrome / AHUS

IndicationStatusPhase
DBCOND0061539 (Atypical Hemolytic Uremic Syndrome (aHUS))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04859608Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)Treatment